Inventor · disambiguated record
Helene Bazin-Lee
Also filed as: BAZIN-LEE HELENE · BAZIN-LEE HELENE G
18 granted patents·7 pending applications·64 citations·filing 2004–2024
91Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA13INIMMUNE CORP3BAZIN-LEE HELENE2GLAXOSMITHKLINE LLC2THE UNIV OF MONTANA2
Top patents by PatentIndex Score
25 records- 0194US8802684B2Adenine derivativesGLAXOSMITHKLINE LLC·Filed 2013·Granted Aug 12, 2014·13 cites·10 claims
- 0289US10351582B2Pegylated imidazoquinolinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Jul 16, 2019·3 cites·9 claims
- 0388US8563717B2Adenine derivativesBAZIN-LEE HELENE·Filed 2009·Granted Oct 22, 2013·15 cites·11 claims
- 0487US8575340B2Purine derivatives and their pharmaceutical usesBAZIN-LEE HELENE·Filed 2011·Granted Nov 5, 2013·13 cites·7 claims
- 0583US7288640B2Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates thereforCORIXA CORP·Filed 2004·Granted Oct 30, 2007·15 cites·43 claims
- 0681US10774099B2Phospholipidation of imidazoquinolines and oxoadeninesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Sep 15, 2020·2 cites·11 claims
- 0775US10882876B2Pegylated imidazoquinolines as TLR7 and TLR8 agonistsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Jan 5, 2021·1 cites·12 claims
- 0874US11964014B2Vaccine adjuvants based on TLR receptor ligandsTHE UNIV OF MONTANA·Filed 2023·Granted Apr 23, 2024·0 cites·10 claims
- 0972US10646566B2Compositions and usesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted May 12, 2020·1 cites·16 claims
- 1072US2025170156A1Toll-like receptor ligandsINIMMUNE CORP·Filed 2024·Application pending·0 cites
- 1171US10584125B2Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Mar 10, 2020·1 cites·6 claims
- 1270US2022144833A1Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1370US2022144865A1Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1470US2022119428A1Phospholipidation of imidazoquinolines and oxoadeninesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1569US12150948B2Toll-like receptor ligandsINIMMUNE CORP·Filed 2022·Granted Nov 26, 2024·0 cites·30 claims
- 1666US12496340B2Vaccine adjuvants based on TLR receptor ligandsTHE UNIV OF MONTANA·Filed 2020·Granted Dec 16, 2025·0 cites·21 claims
- 1766US11248012B2Phospholipidation of imidazoquinolines and oxoadeninesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Feb 15, 2022·0 cites·16 claims
- 1863US10919894B2Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Feb 16, 2021·0 cites·2 claims
- 1962US11207404B2Compositions and usesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Dec 28, 2021·0 cites·6 claims
- 2061US11274115B2Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Mar 15, 2022·0 cites·23 claims
- 2158US11458151B2Toll-like receptor ligandsINIMMUNE CORP·Filed 2019·Granted Oct 4, 2022·0 cites·23 claims
- 2252US2011135671A1Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseasesGLAXOSMITHKLINE LLC·Filed 2009·Application pending·0 cites
- 2351US2021371440A1Tlr7 and / or tlr8 agonistsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 2449US2023416257A1Toll-like receptor agonistUNIV OF MONTANA·Filed 2021·Application pending·0 cites
- 2545US11464854B2Methods and compositions relating to adjuvantsCHILDRENS MEDICAL CENTER·Filed 2018·Granted Oct 11, 2022·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →